Log in
Enquire now

List of UCL Business Ltd patents

List of UCL Business Ltd patents
List of Walters Gardens, Inc. patents
List of Sanofi Pasteur patents
List of Montana State University patents
List of The Brandery Aug 2011 companies
List of companies in Octerra Capital's investment portfolio
Patents where
Current Assignee
Name
is
UCL Business LtdUCL Business Ltd
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11647957 Ultrasound probe

Patent 11647957 was granted and assigned to UCL Business Ltd on May, 2023 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11647957
May 16, 2023
‌
US Patent 11485995 Membrane-spanning nanopores

Patent 11485995 was granted and assigned to UCL Business Ltd on November, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11485995
November 1, 2022
‌
US Patent 10925943 Marker-suicide gene useful in adoptive cell therapy

Patent 10925943 was granted and assigned to UCL Business Ltd on February, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10925943
February 23, 2021
‌
US Patent 11413374 Osteochondral scaffold

Patent 11413374 was granted and assigned to UCL Business Ltd on August, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11413374
August 16, 2022
‌
US Patent 11517631 Factor IX encoding nucleotides

Patent 11517631 was granted and assigned to UCL Business Ltd on December, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11517631
December 6, 2022
‌
US Patent 11344608 Factor IX gene therapy

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11344608
May 31, 2022
‌
US Patent 11492408 Bi-specific T-cell engager specific for BCMA

Patent 11492408 was granted and assigned to UCL Business Ltd on November, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11492408
November 8, 2022
‌
US Patent 11643451 T cell receptor

Patent 11643451 was granted and assigned to UCL Business Ltd on May, 2023 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11643451
May 9, 2023
‌
US Patent 11506625 Diamond-based sensor device for use in hostile environments

Patent 11506625 was granted and assigned to UCL Business Ltd on November, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11506625
November 22, 2022
‌
US Patent 11306142 Bispecific antibodies to ROR1 and CD3

Patent 11306142 was granted and assigned to UCL Business Ltd on April, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11306142
April 19, 2022
‌
US Patent 11466083 ROR1 antibodies

Patent 11466083 was granted and assigned to UCL Business Ltd on October, 2022 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11466083
October 11, 2022
‌
US Patent 11040021 Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies

Patent 11040021 was granted and assigned to UCL Business Ltd on June, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11040021
June 22, 2021
‌
US Patent 11419839 Therapeutic use of compounds

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11419839
August 23, 2022
‌
US Patent 11634391 Compounds which are inhibitors of Notum

Patent 11634391 was granted and assigned to UCL Business Ltd on April, 2023 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11634391
April 25, 2023
‌
US Patent 10947538 Allele-specific gene suppression

Patent 10947538 was granted and assigned to UCL Business Ltd on March, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10947538
March 16, 2021
‌
US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists

Patent 8790647 was granted and assigned to UCL Business Ltd on July, 2014 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
8790647
July 29, 2014
‌
US Patent 11006881 Detecting activity in peripheral nerves

Patent 11006881 was granted and assigned to UCL Business Ltd on May, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11006881
May 18, 2021
‌
US Patent 10730942 Protein-based T-cell receptor knockdown

Patent 10730942 was granted and assigned to UCL Business Ltd on August, 2020 by the United States Patent and Trademark Office.

‌
UCL Business
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10730942
August 4, 2020
‌
US Patent 11560380 Substituted naphthalene diimides and their use

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11560380
January 24, 2023
‌
US Patent 11004506 Switching resistor and method of making such a device

Patent 11004506 was granted and assigned to UCL Business Ltd on May, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11004506
May 11, 2021
‌
US Patent 10874611 Chemotactic, drug-containing polymersomes

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10874611
December 29, 2020
‌
US Patent 10842885 Factor IX encoding nucleotides

‌
UCL Business
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10842885
November 24, 2020
‌
US Patent 10632229 Tissue engineering

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10632229
April 28, 2020
‌
US Patent 11031551 Light-activated switching resistor, an optical sensor incorporating a light-activated switching resistor, and methods of using such devices

Patent 11031551 was granted and assigned to UCL Business Ltd on June, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11031551
June 8, 2021
‌
US Patent 11071720 Cancer therapy

Patent 11071720 was granted and assigned to UCL Business Ltd on July, 2021 by the United States Patent and Trademark Office.

UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
UCL Business Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11071720
July 27, 2021
Results per page:
49 results
0 selected
49 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us